$PPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Avid Bioservices, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Avid Bioservices, Inc.. Get notifications about new insider transactions in Avid Bioservices, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | PPHM | Avid Bioservices, ... | Hancock Richard B | Director | Option Exercise | M | 0.00 | 4,987 | 0 | 40,410 | |
May 07 2021 | PPHM | Avid Bioservices, ... | Hancock Richard B | Director | Buy | M | 0.00 | 4,987 | 0 | 30,795 | 25.8 K to 30.8 K (+19.32 %) |
Apr 14 2021 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | J | 21.00 | 900 | 18,900 | 0 | |
Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Buy | P | 18.18 | 126,000 | 2,290,680 | 126,000 | 0 to 126 K |
Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Sell | S | 18.18 | 26,000 | 472,680 | 0 | 26 K to 0 (-100.00 %) |
Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Sell | S | 18.18 | 100,000 | 1,818,000 | 0 | 100 K to 0 (-100.00 %) |
Jan 04 2021 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Buy | J | 6.06 | 1,754 | 10,623 | 19,737 | 18 K to 19.7 K (+9.75 %) |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | MACKEY CATHERINE J | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | MACKEY CATHERINE J | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 61,805 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 45,397 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 253,900 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
Dec 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
Jul 31 2020 | PPHM | Avid Bioservices, ... | Green Nicholas Stewart | President & CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jul 31 2020 | PPHM | Avid Bioservices, ... | Green Nicholas Stewart | President & CEO | Option Exercise | A | 7.26 | 75,000 | 544,500 | 75,000 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 0.00 | 15,110 | 0 | 46,648 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 0.00 | 15,110 | 0 | 46,648 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 6.95 | 55,310 | 384,405 | 292,717 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 6.95 | 55,310 | 384,405 | 292,717 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | M | 0.00 | 10,512 | 0 | 31,538 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | M | 0.00 | 10,512 | 0 | 31,538 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Sell | S | 6.88 | 3,683 | 25,339 | 6,829 | 10.5 K to 6.8 K (-35.04 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Sell | S | 6.88 | 3,683 | 25,339 | 6,829 | 10.5 K to 6.8 K (-35.04 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Buy | M | 0.00 | 10,512 | 0 | 10,512 | 0 to 10.5 K |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Buy | M | 0.00 | 10,512 | 0 | 10,512 | 0 to 10.5 K |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | A | 0.00 | 19,425 | 0 | 37,024 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | A | 0.00 | 19,425 | 0 | 37,024 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | A | 6.95 | 71,120 | 494,284 | 232,880 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | A | 6.95 | 71,120 | 494,284 | 232,880 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,866 | 0 | 17,599 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,866 | 0 | 17,599 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Sell | S | 6.88 | 2,056 | 14,145 | 17,983 | 20 K to 18 K (-10.26 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Sell | S | 6.88 | 2,056 | 14,145 | 17,983 | 20 K to 18 K (-10.26 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Buy | M | 0.00 | 5,866 | 0 | 20,039 | 14.2 K to 20 K (+41.39 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hart Daniel R | Chief Financial Off ... | Buy | M | 0.00 | 5,866 | 0 | 20,039 | 14.2 K to 20 K (+41.39 %) |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 0.00 | 28,055 | 0 | 43,018 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 0.00 | 28,055 | 0 | 43,018 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 6.95 | 102,730 | 713,974 | 243,870 | |
Jul 14 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 6.95 | 102,730 | 713,974 | 243,870 | |
May 08 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | M | 0.00 | 4,987 | 0 | 14,963 | |
May 08 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Payment of Exercise | F | 6.22 | 1,679 | 10,443 | 25,808 | 27.5 K to 25.8 K (-6.11 %) |
May 08 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | M | 0.00 | 4,987 | 0 | 27,487 | 22.5 K to 27.5 K (+22.16 %) |
Mar 25 2020 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Buy | P | 3.22 | 30,000 | 96,600 | 30,000 | 0 to 30 K |
Mar 17 2020 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Buy | P | 3.77 | 6,500 | 24,505 | 12,482 | 6 K to 12.5 K (+108.66 %) |
Mar 17 2020 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Buy | P | 3.75 | 1,000 | 3,750 | 5,982 | 5 K to 6 K (+20.07 %) |
Mar 16 2020 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | P | 3.99 | 12,500 | 49,875 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Mar 16 2020 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Buy | P | 4.01 | 12,500 | 50,125 | 66,945 | 54.4 K to 66.9 K (+22.96 %) |
Mar 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Buy | P | 4.01 | 26,000 | 104,260 | 26,000 | 0 to 26 K |
Jan 13 2020 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | MACKEY CATHERINE J | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 51,775 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | MACKEY CATHERINE J | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 51,775 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Jan 13 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
Oct 31 2019 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Buy | J | 3.94 | 2,693 | 10,621 | 4,982 | 2.3 K to 5 K (+117.65 %) |
Sep 12 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | P | 5.10 | 4,700 | 23,970 | 10,000 | 5.3 K to 10 K (+88.68 %) |
Sep 12 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | P | 5.10 | 200 | 1,019 | 5,300 | 5.1 K to 5.3 K (+3.92 %) |
Sep 12 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | P | 5.09 | 1,300 | 6,617 | 5,100 | 3.8 K to 5.1 K (+34.21 %) |
Sep 12 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Buy | P | 5.08 | 3,800 | 19,304 | 3,800 | 0 to 3.8 K |
Sep 12 2019 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Buy | P | 5.10 | 5,000 | 25,500 | 54,445 | 49.4 K to 54.4 K (+10.11 %) |
Sep 12 2019 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Buy | P | 5.00 | 5,000 | 25,000 | 49,445 | 44.4 K to 49.4 K (+11.25 %) |
Jul 26 2019 | PPHM | Avid Bioservices, ... | MACKEY CATHERINE J | Director | Option Exercise | A | 6.38 | 32,100 | 204,798 | 32,100 | |
Jul 11 2019 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 0.00 | 42,050 | 0 | 42,050 | |
Jul 11 2019 | PPHM | Avid Bioservices, ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | A | 6.07 | 98,120 | 595,588 | 237,407 | |
Jul 11 2019 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Option Exercise | A | 0.00 | 23,465 | 0 | 23,465 | |
Jul 11 2019 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Option Exercise | A | 6.07 | 54,760 | 332,393 | 161,760 | |
May 08 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 0.00 | 19,950 | 0 | 19,950 | |
May 08 2019 | PPHM | Avid Bioservices, ... | Hancock Richard B | Interim President & ... | Option Exercise | A | 4.53 | 46,540 | 210,826 | 141,140 | |
Apr 30 2019 | PPHM | Avid Bioservices, ... | Lias Roger J. | President & CEO | Buy | J | 4.07 | 2,289 | 9,320 | 2,289 | 0 to 2.3 K |
Apr 30 2019 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Buy | J | 4.07 | 2,289 | 9,320 | 2,289 | 0 to 2.3 K |
Dec 18 2018 | PPHM | Avid Bioservices, ... | Walsh Patrick D | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Dec 18 2018 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Dec 18 2018 | PPHM | Avid Bioservices, ... | McComb Joel | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Dec 18 2018 | PPHM | Avid Bioservices, ... | Hancock Richard B | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Dec 18 2018 | PPHM | Avid Bioservices, ... | CARLEONE JOSEPH | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Dec 18 2018 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
Sep 21 2018 | PPHM | Avid Bioservices, ... | McComb Joel | Director | Sell | S | 6.57 | 24,267 | 159,500 | 0 | 24.3 K to 0 (-100.00 %) |
Sep 21 2018 | PPHM | Avid Bioservices, ... | McComb Joel | Director | Sell | S | 6.48 | 25,733 | 166,786 | 24,267 | 50 K to 24.3 K (-51.47 %) |
Aug 03 2018 | PPHM | Avid Bioservices, ... | Hart Daniel Ryan | Chief Financial Off ... | Option Exercise | A | 5.66 | 107,000 | 605,620 | 0 | |
May 03 2018 | PPHM | Avid Bioservices, ... | Lias Roger J. | President & CEO | Option Exercise | A | 3.38 | 50,000 | 169,000 | 200,000 | |
Nov 29 2017 | PPHM | PEREGRINE PHARMACE ... | SARGEN GREGORY | Director | Option Exercise | A | 4.67 | 75,000 | 350,250 | 75,000 | |
Nov 29 2017 | PPHM | PEREGRINE PHARMACE ... | McComb Joel | Director | Option Exercise | A | 4.67 | 75,000 | 350,250 | 75,000 | |
Nov 29 2017 | PPHM | PEREGRINE PHARMACE ... | Hancock Richard B | Director | Option Exercise | A | 4.67 | 75,000 | 350,250 | 75,000 | |
Nov 29 2017 | PPHM | PEREGRINE PHARMACE ... | CARLEONE JOSEPH | Director | Option Exercise | A | 4.67 | 75,000 | 350,250 | 75,000 | |
Nov 01 2017 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Buy | J | 3.87 | 2,747 | 10,624 | 16,187 | 13.4 K to 16.2 K (+20.44 %) |
Nov 01 2017 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 3.87 | 1,398 | 5,407 | 34,646 | 33.2 K to 34.6 K (+4.20 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.51 | 1,200 | 5,412 | 50,000 | 48.8 K to 50 K (+2.46 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.51 | 35,966 | 162,063 | 48,800 | 12.8 K to 48.8 K (+280.24 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 5,340 | 23,993 | 12,834 | 7.5 K to 12.8 K (+71.26 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 201 | 903 | 7,494 | 7.3 K to 7.5 K (+2.76 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 300 | 1,347 | 7,293 | 7 K to 7.3 K (+4.29 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 1,800 | 8,080 | 6,993 | 5.2 K to 7 K (+34.66 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 4,993 | 22,399 | 5,193 | 200 to 5.2 K (+2,496.50 %) |
Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.48 | 200 | 895 | 200 | 0 to 200 |
Oct 24 2017 | PPHM | PEREGRINE PHARMACE ... | Walsh Patrick D | Director | Option Exercise | A | 4.08 | 75,000 | 306,000 | 75,000 | |
Oct 24 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Option Exercise | A | 3.88 | 75,000 | 291,000 | 75,000 | |
Sep 27 2017 | PPHM | PEREGRINE PHARMACE ... | Lias Roger J. | President *** | Option Exercise | A | 3.19 | 150,000 | 478,500 | 150,000 | |
Aug 29 2017 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | J | 3.50 | 4,706 | 16,474 | 253,541 | |
Aug 29 2017 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | J | 9.17 | 15,966 | 146,408 | 258,247 | |
Aug 29 2017 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | J | 9.17 | 11,908 | 109,196 | 262,305 | |
Aug 29 2017 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | J | 3.50 | 14,934 | 52,279 | 239,255 | |
Aug 29 2017 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | J | 9.17 | 20,024 | 183,620 | 254,189 | |
Apr 28 2017 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Buy | J | 0.27 | 39,177 | 10,625 | 94,079 | 54.9 K to 94.1 K (+71.36 %) |
Apr 28 2017 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.27 | 37,389 | 10,140 | 184,038 | 146.6 K to 184 K (+25.50 %) |
Apr 28 2017 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.27 | 19,941 | 5,408 | 232,730 | 212.8 K to 232.7 K (+9.37 %) |
Nov 01 2016 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Buy | J | 0.29 | 33,783 | 9,675 | 54,902 | 21.1 K to 54.9 K (+159.96 %) |
Nov 01 2016 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.29 | 33,783 | 9,675 | 146,649 | 112.9 K to 146.6 K (+29.93 %) |
Nov 01 2016 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.29 | 18,826 | 5,392 | 212,789 | 194 K to 212.8 K (+9.71 %) |
Nov 01 2016 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.29 | 25,433 | 7,284 | 135,908 | 110.5 K to 135.9 K (+23.02 %) |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | VP and General Coun ... | Option Exercise | A | 0.50 | 150,000 | 75,015 | 975,000 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 0.50 | 200,000 | 100,020 | 1,919,500 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Option Exercise | A | 0.50 | 150,000 | 75,015 | 1,035,000 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 0.50 | 200,000 | 100,020 | 1,919,500 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 0.50 | 250,000 | 125,025 | 1,547,500 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 0.50 | 500,000 | 250,050 | 2,976,137 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 0.50 | 200,000 | 100,020 | 1,919,500 | |
Jun 03 2016 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 0.50 | 150,000 | 75,015 | 893,000 | |
May 24 2016 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | P | 3.00 | 300 | 900 | 900 | |
May 24 2016 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | P | 3.00 | 300 | 900 | 600 | |
May 24 2016 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V. P., General Coun ... | Option Exercise | P | 3.00 | 300 | 900 | 300 | |
May 02 2016 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Buy | J | 0.30 | 10,683 | 3,216 | 21,119 | 10.4 K to 21.1 K (+102.37 %) |
May 02 2016 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.30 | 10,683 | 3,216 | 193,963 | 183.3 K to 194 K (+5.83 %) |
May 02 2016 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.30 | 10,683 | 3,216 | 110,475 | 99.8 K to 110.5 K (+10.71 %) |
Nov 02 2015 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.95 | 6,158 | 5,850 | 112,866 | 106.7 K to 112.9 K (+5.77 %) |
Nov 02 2015 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.95 | 5,474 | 5,200 | 183,280 | 177.8 K to 183.3 K (+3.08 %) |
Nov 02 2015 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.95 | 8,448 | 8,026 | 99,792 | 91.3 K to 99.8 K (+9.25 %) |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V.P., General Couns ... | Option Exercise | A | 1.31 | 100,000 | 131,000 | 825,000 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 1.31 | 187,500 | 245,625 | 1,719,500 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Option Exercise | A | 1.31 | 100,000 | 131,000 | 885,000 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 1.31 | 187,500 | 245,625 | 1,719,500 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 1.31 | 150,000 | 196,500 | 1,297,500 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 1.31 | 300,000 | 393,000 | 2,476,137 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 1.31 | 187,500 | 245,625 | 1,719,500 | |
May 12 2015 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 1.31 | 75,000 | 98,250 | 743,000 | |
May 01 2015 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 1.11 | 5,217 | 5,791 | 106,708 | 101.5 K to 106.7 K (+5.14 %) |
May 01 2015 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 1.11 | 4,634 | 5,144 | 177,806 | 173.2 K to 177.8 K (+2.68 %) |
May 01 2015 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 1.11 | 7,179 | 7,969 | 91,344 | 84.2 K to 91.3 K (+8.53 %) |
Nov 04 2014 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 1.36 | 3,280 | 4,461 | 173,172 | 169.9 K to 173.2 K (+1.93 %) |
Nov 04 2014 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 1.36 | 5,362 | 7,292 | 84,165 | 78.8 K to 84.2 K (+6.80 %) |
May 08 2014 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V.P., General Couns ... | Option Exercise | A | 1.75 | 175,000 | 306,250 | 735,000 |